Literature DB >> 28523486

Esophagectomy with Esophagocoloplasty for Malignancies: Indications, Technique (with Video), and Results. Systematic Review of the Literature.

Paolo Aurello1, Niccolo' Petrucciani2,3, Dario Sirimarco1, Livia Maria Mangogna1, Giuseppe Nigri1, Stefano Valabrega1, Francesco D'Angelo1, Giovanni Ramacciato1.   

Abstract

INTRODUCTION: Esophagocoloplasty represents a useful technique to restore the intestinal continuity after esophagogastrectomy. This technique has been used mainly after esophagogastric caustic injuries. The aim of this review is to assess the role of esophagogastrectomy with esophagocoloplasty for esophageal or gastric neoplasms.
METHODS: A systematic literature search was performed using Embase, Medline, Cochrane, and PubMed databases to identify all studies published in the previous 25 years (1991-2016) reporting cases of esophagocoloplasty after esophagogastrectomy for malignancies. The systematic review was conducted according to the PRISMA guidelines.
RESULTS: The systematic review of the literature shows a morbidity rate of 57% and a mortality rate of 15% in the 93 reported cases of esophagocoloplasty performed for malignant diseases. However, R0 rate ranged from 76.1 to 85%, and 5-year survival was obtained in 11.9-32.8% of patients in the different series.
CONCLUSIONS: In highly selected cases of primary or relapsing gastric or esophageal neoplasms, esophagogastrectomy with esophagocoloplasty is a viable and useful option, which may guarantee complete tumor resection and long-term survival.

Entities:  

Keywords:  Cancer; Esophagectomy; Esophagocoloplasty; Recurrence; Video

Mesh:

Year:  2017        PMID: 28523486     DOI: 10.1007/s11605-017-3449-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  8 in total

1.  Upper digestive tract reconstruction for caustic injuries.

Authors:  Mircea Chirica; Marie-Dominique Brette; Matthieu Faron; Nicolas Munoz Bongrand; Bruno Halimi; Christine Laborde; Emile Sarfati; Pierre Cattan
Journal:  Ann Surg       Date:  2015-05       Impact factor: 12.969

2.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

3.  Similar outcomes after primary and secondary esophagocoloplasty for caustic injuries.

Authors:  Mircea Chirica; Helene Vuarnesson; Sarah Zohar; Matthieu Faron; Bruno Halimi; Nicolas Munoz Bongrand; Pierre Cattan; Emile Sarfati
Journal:  Ann Thorac Surg       Date:  2012-03       Impact factor: 4.330

4.  Left colonic graft in esophageal reconstruction for caustic stricture: mortality and morbidity.

Authors:  A Boukerrouche
Journal:  Dis Esophagus       Date:  2012-08-07       Impact factor: 3.429

5.  Total esophagogastrectomy plus extended lymphadenectomy with transverse colon interposition: A treatment for extensive esophagogastric junction cancer.

Authors:  Marco Ceroni; Enrique Norero; Juan Pablo Henríquez; Eduardo Viñuela; Eduardo Briceño; Cristian Martínez; Gloria Aguayo; Fernando Araos; Paulina González; Alfonso Díaz; Mario Caracci
Journal:  World J Hepatol       Date:  2015-10-08

6.  Combined total gastrectomy, total esophagectomy, and D2 lymph node dissection with transverse colonic interposition for adenocarcinoma of the gastroesophageal junction.

Authors:  Jean M Butte; Enrique Waugh; Hugo Parada; Hernán De La Fuente
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

7.  Esophagocoloplasty for congenital, benign and malignant diseases. Surgical and long-term functional results.

Authors:  E Pompeo; I Nofroni; D Van Raemdonck; W Coosemans; B Van Cleynenbreughel; T Lerut
Journal:  Eur J Cardiothorac Surg       Date:  1996       Impact factor: 4.191

8.  Total esophagogastrectomy in the neoplasms of the esophagus and esofagogastric junction: when must be indicated?

Authors:  Nelson Adami Andreollo; João de Souza Coelho Neto; Guilherme Delfino Calomeni; Luiz Roberto Lopes; Valdir Tercioti Junior
Journal:  Rev Col Bras Cir       Date:  2015 Nov-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.